These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16480168)

  • 21. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications.
    Leggio L; Kenna GA; Swift RM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1106-17. PubMed ID: 18029075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baclofen for alcohol withdrawal: not comparable to the gold standard (benzodiazepines).
    Saitz R
    Am J Med; 2007 Jun; 120(6):e9; author reply e11. PubMed ID: 17524741
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
    Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
    Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing alcohol withdrawal in hospitalized patients.
    Hartsell Z; Drost J; Wilkens JA; Budavari AI
    JAAPA; 2007 Sep; 20(9):20-5. PubMed ID: 17902537
    [No Abstract]   [Full Text] [Related]  

  • 25. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of fixed tapering dose regimen versus symptom-triggered regimen of lorazepam for alcohol detoxification.
    Sachdeva A; Chandra M; Deshpande SN
    Alcohol Alcohol; 2014; 49(3):287-91. PubMed ID: 24407777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol Withdrawal Treatment in the Medically Hospitalized Patient: A Pilot Study Assessing Predictors for Medical or Psychiatric Complications.
    Shu JE; Lin A; Chang G
    Psychosomatics; 2015; 56(5):547-55. PubMed ID: 25620568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients.
    González G; Desai R; Sofuoglu M; Poling J; Oliveto A; Gonsai K; Kosten TR
    Drug Alcohol Depend; 2007 Feb; 87(1):1-9. PubMed ID: 16930857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
    Davidson JR; Brady K; Mellman TA; Stein MB; Pollack MH
    J Clin Psychopharmacol; 2007 Feb; 27(1):85-8. PubMed ID: 17224720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment.
    Stock CJ; Carpenter L; Ying J; Greene T
    Ann Pharmacother; 2013; 47(7-8):961-9. PubMed ID: 23780805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam as adjunctive therapy for acute alcohol withdrawal syndrome in hospitalized patients.
    Youland KM; Miller RF; Mahoney LJ; Borgert AJ; Gundrum JD
    J Clin Psychopharmacol; 2014 Dec; 34(6):704-8. PubMed ID: 25144138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
    Pittman B; Gueorguieva R; Krupitsky E; Rudenko AA; Flannery BA; Krystal JH
    Alcohol Clin Exp Res; 2007 Apr; 31(4):612-8. PubMed ID: 17374040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence, Predictors, and Prognosis of Alcohol Withdrawal Syndrome and Delirium Tremens Following Traumatic Injury.
    Salottolo K; McGuire E; Mains CW; van Doorn EC; Bar-Or D
    Crit Care Med; 2017 May; 45(5):867-874. PubMed ID: 28266937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
    Walsh JK; Perlis M; Rosenthal M; Krystal A; Jiang J; Roth T
    J Clin Sleep Med; 2006 Jan; 2(1):35-41. PubMed ID: 17557435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective review and assessment of benzodiazepines in the treatment of alcohol withdrawal in hospitalized patients.
    Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1994; 14(5):572-8. PubMed ID: 7997390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and therapeutic aspects of alcohol withdrawal syndrome].
    Miniati M; Bani A; Mauri M
    Minerva Psichiatr; 1993 Sep; 34(3):173-9. PubMed ID: 8302190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tiagabine in anxiety disorders.
    Schwartz TL; Nihalani N
    Expert Opin Pharmacother; 2006 Oct; 7(14):1977-87. PubMed ID: 17020423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
    Walsh JK; Zammit G; Schweitzer PK; Ondrasik J; Roth T
    Sleep Med; 2006 Mar; 7(2):155-61. PubMed ID: 16260179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepine loading versus symptom-triggered treatment of alcohol withdrawal: a prospective, randomized clinical trial.
    Maldonado JR; Nguyen LH; Schader EM; Brooks JO
    Gen Hosp Psychiatry; 2012; 34(6):611-7. PubMed ID: 22898443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.